Curative Biosciences, Inc. CBDX

Company Overview

Curative Biosciences, Inc. (OTC: CBDX) is a publicly traded biotechnology and wellness-focused company that has historically operated in the cannabinoid, nutraceutical, and health sciences sectors. Public disclosures indicate that the company has pursued business activities involving cannabinoid-based products, bioscience research initiatives, and intellectual property development tied to therapeutic and wellness applications. The company trades on the OTC market and has been associated with efforts to reposition itself from earlier cannabis-oriented operations toward broader bioscience and health-related commercialization strategies.

The company’s reported business model has centered on developing or acquiring health-focused products, licensing opportunities, and related commercial assets. Available public filings and OTC disclosures suggest that management has explored strategic transactions, restructuring initiatives, and partnerships intended to expand beyond commodity cannabis exposure into higher-margin bioscience and therapeutic opportunities. Data regarding long-term commercial scale, sustained operating revenue, and market share remains limited in publicly available filings, and certain operational details are inconclusive based on available public sources.